Plasminogen Activator Inhibitor-1 Predicts Negative Alterations in Whole-Body Insulin Sensitivity in Chronic HIV Infection

Plasminogen activator inhibitor type 1 (PAI-1), a key negative regulator of fibrinolysis, has been investigated to be one of the potential mechanisms of the development of impaired insulin sensitivity, insulin resistance, and diabetes mellitus. Because chronically stable HIV-infected individuals fre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Res Hum Retroviruses
Main Authors: Wirunsawanya, Kamonkiat, Belyea, Loni, Shikuma, Cecilia, Watanabe, Richard M., Kohorn, Lindsay, Shiramizu, Bruce, Mitchell, Brooks I., Souza, Scott A., Keating, Sheila M., Norris, Philip J., Ndhlovu, Lishomwa C., Chow, Dominic
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2017
Assuntos:
Pathogenesis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749045/
https://ncbi.nlm.nih.gov/pubmed/28322572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2016.0292
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados